Considering its effects on autophagy and apoptosis, when tested in an in vivo model of FLT3-ITD AML, the combination of nanoliposomal C6-ceramide with vinblastine had synergistic effects, supporting other recent studies [198,201]. The gene discussed is FLT3; the disease is acute myeloid leukemia.